Bracco Drug Patent Portfolio
Bracco owns 5 orange book drugs protected by 9 US patents with Cardiotec having the least patent protection, holding only 1 patent. And Lumason with maximum patent protection, holding 4 patents. Given below is the list of Bracco's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11723869 | Freeze-dried product and gas-filled microvesicles suspension | 15 May, 2039 | Active |
| US10232061 | Freeze-dried formulation for gas-filled microvesicles | 06 Jul, 2038 | Active |
| US10335502 | Freeze-dried formulation for gas-filled microvesicles | 06 Jul, 2038 | Active |
| US6803046 | Sincalide formulations | 16 Aug, 2022 | Expired |
| US5686060 | Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography | 11 Nov, 2019 | Expired |
| US6056941 | Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent | 28 Jul, 2019 | Expired |
| US5846519 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | 08 Dec, 2015 | Expired |
| US5474756 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | 12 Dec, 2012 | Expired |
| US6143274 | Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | 12 Dec, 2012 | Expired |
Latest Legal Activities on Bracco's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Bracco.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 15 Aug, 2023 | US11723869 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Aug, 2023 | US11723869 |
|
Email Notification
Critical
| 15 Aug, 2023 | US11723869 |
| Recordation of Patent eGrant | 15 Aug, 2023 | US11723869 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2023 | US11723869 |
| Mail Patent eGrant Notification | 15 Aug, 2023 | US11723869 |
|
Email Notification
Critical
| 27 Jul, 2023 | US11723869 |
|
Electronic Review
Critical
| 27 Jul, 2023 | US11723869 |
|
Issue Notification Mailed
Critical
| 26 Jul, 2023 | US11723869 |
| Dispatch to FDC | 29 Jun, 2023 | US11723869 |
|
Application Is Considered Ready for Issue
Critical
| 29 Jun, 2023 | US11723869 |
|
Issue Fee Payment Verified
Critical
| 26 Jun, 2023 | US11723869 |
|
Issue Fee Payment Received
Critical
| 26 Jun, 2023 | US11723869 |
|
Electronic Review
Critical
| 29 Mar, 2023 | US11723869 |
|
Mail Notice of Allowance
Critical
| 29 Mar, 2023 | US11723869 |
Bracco's Drug Patent Litigations
Bracco's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 19, 2018, against patent number US6803046. The petitioner Maia Pharmaceuticals, Inc., challenged the validity of this patent, with Bracco Diagnostics Inc. as the respondent. Click below to track the latest information on how companies are challenging Bracco's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6803046 | November, 2018 |
Terminated-Denied
(31 May, 2019)
| Bracco Diagnostics Inc. | Maia Pharmaceuticals, Inc. |
Bracco's Family Patents
Bracco Drug List
Given below is the complete list of Bracco's drugs and the patents protecting them.
1. Cardiotec
Cardiotec is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6056941 | Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent |
28 Jul, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardiotec's drug page
2. Kinevac
Kinevac is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6803046 | Sincalide formulations |
16 Aug, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kinevac's drug page
3. Lumason
Lumason is protected by 4 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11723869 | Freeze-dried product and gas-filled microvesicles suspension |
15 May, 2039
(14 years from now)
| Active |
| US10232061 | Freeze-dried formulation for gas-filled microvesicles |
06 Jul, 2038
(13 years from now)
| Active |
| US10335502 | Freeze-dried formulation for gas-filled microvesicles |
06 Jul, 2038
(13 years from now)
| Active |
| US5686060 | Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography |
11 Nov, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lumason's drug page
4. Prohance
Prohance is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5846519 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
08 Dec, 2015
(9 years ago)
| Expired |
| US5474756 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
12 Dec, 2012
(12 years ago)
| Expired |
| US6143274 | Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
12 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prohance's drug page
5. Prohance Multipack
Prohance Multipack is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5846519 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
08 Dec, 2015
(9 years ago)
| Expired |
| US5474756 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
12 Dec, 2012
(12 years ago)
| Expired |
| US6143274 | Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
12 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prohance Multipack's drug page